Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: a 30-week, double-blind, phase 3a, randomized trial
Subgroup meta-analyses based on participants kidney function indicated that the salutary effects of SGLT2i on MACE, cardiovascular death or HHF, and a composite kidney outcome (substantial loss of kidney function, end-stage kidney disease or death due to kidney disease) do not significantly differ among subgroups based on eGFR [142, 252]
Jason Finkelstein (MD), will oversee your treatment plan and ensure its customized to your specific health profile and weight loss goals
Lowering caffeine during this period improves hydration, reduces acid reflux, and eases gastrointestinal workload, supporting better tolerance of the medication